87 results on '"Harrison, Lee"'
Search Results
2. Meningococcal Disease in Patients With Human Immunodeficiency Virus Infection: A Review of Cases Reported Through Active Surveillance in the United States, 2000–2008
3. Penicillin Use in Meningococcal Disease Management: Active Bacterial Core Surveillance Sites, 2009.
4. 1443. Characteristics of nursing homes with higher rates of invasive methicillin-resistant Staphylococcus aureus infections
5. 2185. In vitro activity of aztreonam-avibactam (ATM-AVI), cefiderocol (FDC), and cefepime-taniborbactam (FEP-TAN) against multi-species, NDM-producing Enterobacterales causing a local outbreak
6. 742. Strain Replacement of Vancomycin-Resistant Enterococcus faecium over 6 years at a Large Tertiary Care Center
7. 1721. BCG Vaccination Impact on Mortality: a 71 year Follow-up of a US BCG Controlled Trial
8. 1718. Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease among children in the United States between 2010 and 2019: an indirect cohort study
9. Invasive Haemophilus influenzae Disease in Adults ≥65 Years, United States, 2011
10. 2317. Persistent Bacterial Carriage and Hospital Transmission Detected by Whole Genome Sequence Surveillance
11. Recurrent Candidemia: Trends and Risk Factors Among Persons Residing in 4 US States, 2011–2018
12. Low Sensitivity of International Classification of Diseases, Tenth Revision Coding for Culture-Confirmed Candidemia Cases in an Active Surveillance System: United States, 2019–2020
13. 1299. Epidemiology of Invasive Pneumococcal Disease (IPD) in the United States 2011-2019
14. 70. Changes in Invasive Pneumococcal Disease among Adults Living with HIV Following Introduction of 13-Valent Pneumococcal Conjugate Vaccine, 2008–2018
15. Low but Increasing Prevalence of Reduced Beta-lactam Susceptibility Among Invasive Group B Streptococcal Isolates, US Population-Based Surveillance, 1998–2018
16. 85. Characterization of Group B streptococcus Strains with Reduced Susceptibility to Beta-lactam Antibiotics, Active Bacterial Core Surveillance, 1998–2017
17. 1470. Epidemiology of Invasive Pneumococcal Disease (IPD) Following 18 years of Pneumococcal Conjugate Vaccine (PCV) Use in the United States
18. 146. antifungal Susceptibility Patterns of candida Parapsilosis Bloodstream Isolates in the US, 2008–2018
19. 1474. Impact of 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Non-bacteremic Pneumococcal Pneumonia (NBPP) among Adults in the United States, 2013-2017
20. 180. Impact of Pneumococcal Conjugative Vaccine on Antibiotic Resistant Invasive Pneumococcal Disease in the United States
21. 469. Contributions of Infections among Persons Who Inject Drugs to the Changing Incidence of Healthcare-Associated, Community-Onset Methicillin-Resistant Staphylococcus aureus Infections, 2009–2017
22. 485. Clinical and Molecular Epidemiology of Carbapenem Non-susceptible Citrobacter sp.
23. Invasive Meningococcal Disease due to Nongroupable Neisseria meningitidis—Active Bacterial Core Surveillance Sites, 2011–2016
24. 1436. Risk Factors for Invasive Pneumococcal Disease in Adults ≥65 Years Old Following Pneumococcal Conjugate Vaccine Recommendation
25. 2065. Whole Genome Sequencing for Antimicrobial Resistance Prediction in MRSA and VRE: A Real-world Application
26. 1230. Epidemiology and Risk Factors for Recurrent Invasive Methicillin-Resistant Staphylococcus aureus Infection: nine US States, 2006–2013
27. 363. National Burden of Candidemia, United States, 2017
28. 1461. Non-Invasive Pneumococcal Pneumonia in the United States, 2013–2014
29. 1722. The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Emerging Risk Factor for Candidemia
30. 151. Evaluation of Pneumococcal Vaccine Effectiveness Against Invasive Pneumococcal Disease Among US Medicare Beneficiaries ≥65 Years Old
31. Low but Increasing Prevalence of Reduced Beta-lactam Susceptibility Among Invasive Group B Streptococcal Isolates, US Population-Based Surveillance, 1998–2018.
32. Obesity, Diabetes, and the Risk of Invasive Group B Streptococcal Disease in Nonpregnant Adults in the United States
33. Prevalence of and Factors Associated with Clostridium difficile Co-infection Among Patients with Candidemia, United States, 2014–2016
34. Changes in invasive pneumococcal disease among adults living with HIV following introduction of 13-valent pneumococcal conjugate vaccine, 2008–2014
35. Direct and Indirect Impact of 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Invasive Pneumococcal Disease (IPD) Among Children and Adults in the U.S.
36. Impact of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Use on Invasive Pneumococcal Disease (IPD) Among Adults With Chronic Conditions, United States
37. Nonpneumococcal Streptococci Confounding Polymerase Chain Reaction Serotyping of Streptococcus pneumoniae in United States Colonized Adults
38. Current Epidemiology and Trends in Invasive Haemophilus influenzae Disease—United States, 2009–2014
39. Direct and Indirect Impact of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Use on Invasive Pneumococcal Disease (IPD) Among Children and Adults
40. Trends in Group B Streptococcal Infections Among Infants <3 Months of Age and the Potential Impact of a Maternal Vaccine in the United States (2006–2014)
41. Epidemiology and Risk Factors for Echinocandin Nonsusceptible Candida glabrata Bloodstream Infections: Data From a Large Multisite Population-Based Candidemia Surveillance Program, 2008–2014
42. Socioeconomic Factors Explain Racial Disparities in Community-Associated Methicillin-Resistant Staphyloccocus aureus Disease Rates
43. Epidemiology and Risk Factors for Fluconazole Resistance and Mortality Among Adults With Candidemia in Atlanta and Baltimore
44. Invasive Methicillin-Resistant Staphylococcus aureus Infections in Residents of Long-Term Care Facilities: Targeted Prevention Efforts Needed
45. 1452Emergence of Echinocandin and Multi-drug Resistant Candida glabrata Bloodstream Infection: Data from a Large Multi-site Population-Based Candidemia Surveillance Program
46. 1718Resistance among Invasive Group A Streptococcal Infections, United States, 1999-2012
47. 887Opportunities to Improve Completeness of MRSA Bloodstream Infection Reporting From Outpatient Hemodialysis Facilities to the National Healthcare Safety Network
48. 1337Obesity, Diabetes, and the Risk of Invasive Group B Streptococcal Disease in Non-Pregnant Adults
49. 737The Impact of Obesity and Diabetes on the Risk and Outcomes of Invasive Group A Streptococcus Infections in Adults, Active Bacterial Core Surveillance (2010-2012)
50. 1646Evidence of hospital-associated Clostridium difficile transmission between patients with asymptomatic carriage and patients with Clostridium difficile infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.